Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ballard

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Seminars in Clinical Neuropsychiatry|February 5, 2003
Dementia with Lewy bodiesIan G McKeith, David J Burn, Clive G Ballard, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2015
Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of DementiaJulie Vallortigara, David Whitfield, William Quelch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthMary O'Leary, Joanna Bowtell, Megan Richards, et al.
Parkinsonism & Related Disorders|May 2, 2021
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsStuart H Isaacson, Clive G Ballard, David L Kreitzman, et al.
Novartis Foundation Symposium|March 31, 2001
Multiple substrates of late-onset dementia: implications for brain protectionR N Kalaria, C G Ballard, P G Ince, et al.
Dementia and Geriatric Cognitive Disorders|November 2, 2002
Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodiesAndrew B Singleton, Anna Wharton, Kirsty K O'Brien, et al.
Neuropathology and Applied Neurobiology|April 8, 2006
Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementiaH Lewis, D Beher, N Cookson, et al.
Parkinsonism & Related Disorders|July 27, 2020
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisClive G Ballard, David L Kreitzman, Stuart Isaacson, et al.
Neurology|March 17, 2000
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodiesI G McKeith, C G Ballard, R H Perry, et al.
The American Journal of Psychiatry|May 4, 2004
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodiesClive G Ballard, Robin Jacoby, Teodoro Del Ser, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Seminars in Clinical Neuropsychiatry|February 5, 2003
Dementia with Lewy bodiesIan G McKeith, David J Burn, Clive G Ballard, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2015
Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of DementiaJulie Vallortigara, David Whitfield, William Quelch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthMary O'Leary, Joanna Bowtell, Megan Richards, et al.
Parkinsonism & Related Disorders|May 2, 2021
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsStuart H Isaacson, Clive G Ballard, David L Kreitzman, et al.
Novartis Foundation Symposium|March 31, 2001
Multiple substrates of late-onset dementia: implications for brain protectionR N Kalaria, C G Ballard, P G Ince, et al.
Dementia and Geriatric Cognitive Disorders|November 2, 2002
Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodiesAndrew B Singleton, Anna Wharton, Kirsty K O'Brien, et al.
Neuropathology and Applied Neurobiology|April 8, 2006
Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementiaH Lewis, D Beher, N Cookson, et al.
Parkinsonism & Related Disorders|July 27, 2020
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisClive G Ballard, David L Kreitzman, Stuart Isaacson, et al.
Neurology|March 17, 2000
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodiesI G McKeith, C G Ballard, R H Perry, et al.
The American Journal of Psychiatry|May 4, 2004
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodiesClive G Ballard, Robin Jacoby, Teodoro Del Ser, et al.
Pageof 17